GENG; Yong-Jian

Patent Applications and Registrations

Patent applications and USPTO patent grants for GENG; Yong-Jian.The latest application filed is for "recombinant clusterin and use thereof in the treatment and prevention of disease".

Company Profile

6.6.18

GENG; Yong-Jian - Houston TX
Geng; Yong-Jian - Pearland TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant Clusterin And Use Thereof In The Treatment And Prevention Of Disease App 20220073591 - GENG; Yong-Jian	2022-03-10
Neuroprotective Liposome Compositions And Methods For Treatment Of Stroke App 20210378959 - HUANG; Shao-Ling ; et al.	2021-12-09
Recombinant clusterin and use thereof in the treatment and prevention of disease Grant 11,104,719 - Geng August 31, 2	2021-08-31
Neuroprotective liposome compositions and methods for treatment of stroke Grant 10,973,764 - Huang , et al. April 13, 2	2021-04-13
Liquids Rich In Noble Gas And Methods Of Their Preparation And Use App 20200215100 - HUANG; Shao-Ling ; et al.	2020-07-09
Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma Grant 10,639,277 - Geng , et al.	2020-05-05
Neuroprotective Liposome Compositions And Methods For Treatment Of Stroke App 20200101015 - HUANG; Shao-Ling ; et al.	2020-04-02
Recombinant Clusterin And Use Thereof In The Treatment And Prevention Of Disease App 20200102369 - GENG; Yong-Jian	2020-04-02
Recombinant clusterin and use thereof in the treatment and prevention of disease Grant 10,464,994 - Geng No	2019-11-05
Neuroprotective liposome compositions and methods for treatment of stroke Grant 10,369,103 - Huang , et al.	2019-08-06
Liquids Rich In Noble Gas And Methods Of Their Preparation And Use App 20180271897 - HUANG; Shao-Ling ; et al.	2018-09-27
Compositions And Methods For Mesenchymal/stromal Stem Cell Rejuvenation And Tissue Repair By Enhanced Co-expression Of Telomerase And Myocardin App 20160243167 - GENG; Yong-Jian ; et al.	2016-08-25
Recombinant Clusterin And Use Thereof In The Treatment And Prevention Of Disease App 20160222088 - GENG; Yong-Jian	2016-08-04
Liquids Rich In Noble Gas And Methods Of Their Preparation And Use App 20160030470 - HUANG; Shao-Ling ; et al.	2016-02-04
Neuroprotective Liposome Compositions And Methods For Treatment Of Stroke App 20150216800 - Huang; Shao-Ling ; et al.	2015-08-06
Compositions And Methods For Mesenchymal/stromal Stem Cell Rejuvenation And Tissue Repair By Enhanced Co-expression Of Telomerase And Myocardin App 20140065112 - MADONNA; Rosalinda ; et al.	2014-03-06
Methods And Compositions For Regulation Of Stem Cell Survival, Proliferation, And Differentiation By Protein Ubiquitination App 20110171681 - GENG; Yong-Jian ; et al.	2011-07-14
Composition And Method For Clusterin-mediated Stem Cell Therapy For Treatment Of Atherosclerosis And Heart Failure App 20090210956 - GENG; Yong-Jian	2009-08-20
Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site Grant 7,524,490 - Geng April 28, 2	2009-04-28
Methods and Compositions for Regulation of Stem Cell Survival, Proliferation, and Differentiation by Protein Ubiquitination App 20080311607 - Geng; Yong-Jian ; et al.	2008-12-18
Compositions and Methods for Myogenesis of Fat-Derived Stem Cells Expressing Telomerase and Myocardin App 20070282456 - Geng; Yong-Jian ; et al.	2007-12-06
Myogenic Development and Protection of Stem Cells Against Inflammation and Apoptosis By Statins and Isoprenoid Pathway Inhibitors App 20070190651 - Geng; Yong-Jian	2007-08-16
Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure App 20060099194 - Geng; Yong-Jian	2006-05-11

Company Registrations

NCAGE Code	47TE6	GENG YONG JIAN
CAGE Code	47TE6	GENG, YONG JIAN
DUNS	611508552	GENG, YONG JIAN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.